Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade enhances incidence and severity of experimental autoimmune neuritis in resistant mice
- 1 April 2001
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 115 (1-2), 111-117
- https://doi.org/10.1016/s0165-5728(01)00255-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CTLA-4 and T cell activationCurrent Opinion in Immunology, 1999
- Induction of experimental autoimmune neuritis in CD4−8− C57BL/6J miceJournal of Neuroimmunology, 1999
- Cytokine Dichotomy in Peripheral Nervous System Influences the Outcome of Experimental Allergic Neuritis: Dynamics of mRNA Expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and CytolysinClinical Immunology and Immunopathology, 1997
- Protective Immunity to Nematode Infection Is Induced by CTLA-4 BlockadeThe Journal of Experimental Medicine, 1997
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995
- Pathogenesis of inflammatory demyelinationCurrent Opinion in Neurology, 1995
- Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis ratsClinical and Experimental Immunology, 1990
- ALLERGIC NEURITIS: AN EXPERIMENTAL DISEASE OF RABBITS INDUCED BY THE INJECTION OF PERIPHERAL NERVOUS TISSUE AND ADJUVANTSThe Journal of Experimental Medicine, 1955